Latest

weight loss

This shows a clock and a brain on a plate.

·July 26, 2026·6 min read

Restricted Eating Windows Aid Cognitive Function

Restricting daily eating to an 8 to 9 hour window yields cognitive improvements in spatial planning and problem-solving for older, overweight women beyond the benefits of caloric reduction alone.

Featured Neuroscience

·July 24, 2026·9 min read

Future Obesity Drugs to Target Specific Brain Circuits

Using site-specific knockout mouse models, researchers found that GIPR agonists suppress appetite via the brainstem, while GIPR antagonists act in the hypothalamus to release a "brake" on hindbrain satiety.

This shows a brain and pills. One half of the brain is red, implying violence.

Featured Neuroscience Psychology

·June 17, 2026·8 min read

Can GLP-1 Medications Blunt the Path to Violence?

GLP-1 receptor agonists, such as Ozempic and Wegovy, may drastically reduce behaviors linked to violence.

This shows a person running and a brain.

Featured Neuroscience

·June 13, 2026·8 min read

GLP-1 Therapies Silence Spontaneous Physical Activity

A new study demonstrates that adults managing obesity significantly decrease their physical activity after starting GLP-1 receptor agonist medications.

Featured Neuroscience

·May 22, 2026·8 min read

Study Aims to Break GLP-1 Weight-Loss Plateaus

The weight-loss effects of semaglutide depend on boosting a signaling molecule called cAMP within appetite-regulating neurons in the area postrema.

Featured Neuroscience

·May 12, 2026·7 min read

GLP-1 Drugs Dramatically Reduce “Food Noise” in Weight Loss

GLP-1 medications effectively "turn down the volume" on intrusive food thoughts. In a study of 417 adults, those combining medication with behavioral therapy saw a significantly greater reduction in "food noise" than those using therapy alone, offering a potential neurobiological explanation for the success of these new obesity treatments.

This shows a woman on a scale with people pointing at her.

Featured Neuroscience Psychology

·April 17, 2026·8 min read

Decoding the Shame Associated with Ozempic Weight Loss

Women using GLP-1 drugs for weight loss face higher levels of stigma than those using diet and exercise, with many critics viewing the medication as a "shortcut."

Featured Genetics Neuroscience

·April 8, 2026·8 min read

Ozempic Weight Loss Success Varies by DNA

A new study of 28,000 people identifies genetic markers in the GLP1R and GIPR genes that explain why some patients lose more weight or experience more nausea on GLP-1 drugs.

Featured Neuroscience Psychology

·March 26, 2026·7 min read

Repetition is Key: Eating the Same Meals Speeds Up Weight Loss

A 12-week study shows that repeating the same meals leads to greater weight loss. By reducing decision fatigue, "routinized eating" helps people lose 5.9% of their body weight compared to 4.3% for those eating varied diets.

Featured Neuroscience

·March 10, 2026·13 min read

Why GLP-1 Drugs Affect Men and Women Differently

A new atlas reveals that GLP-1—the backbone of blockbuster weight-loss drugs—is mapped differently in the male and female brain.

This illustration shows a brain on top of a weighting scale, representing the neural pathway associated with weight loss.

Featured Neuroscience

·February 15, 2026·7 min read

Newly Discovered Brain Pathway Triggers Weight Loss

Scientists have found a "master switch" in the brain that can trigger the rapid elimination of body fat, even while maintaining a normal diet.

This shows metabolic pathways in the brain.

Featured Neurology Neuroscience

·February 13, 2026·9 min read

Parkinson’s Triggers a Hidden Metabolic Shift

Think Parkinson's weight loss is just about nutrition? New research shows it’s actually a sign of an internal energy engine failure. By switching to a fat-burning "emergency engine," the body tries to compensate for a brain in crisis, making thinness a vital biological warning sign.